On February 6, 2019, in conjunction with plasma exchange and immunosuppressive treatment, the Food and Drug Administration approved caplacizumab-yhdp (CABLIVI, Ablynx NV) for adult patients with acqui...
immunosuppressive-therapy
Aplastic Anemia Treatment
Aplastic anemia is a severe yet rare blood disorder in which the bone marrow does not produce adequate blood cells, resulting in symptoms of fatigue, infections, and uncontr...
immunosuppressive-therapy